Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Marilyn B. Kroeger Smith"'
Autor:
Robert C. Rizzo, De-Ping Wang, Richard H. Smith, Marina Udier-Blagovic, Marilyn B. Kroeger Smith, Edward K. Watkins, William L. Jorgensen, Julian Tirado-Rives
Publikováno v:
Journal of Medicinal Chemistry. 45:2970-2987
Results of Monte Carlo (MC) simulations for more than 200 nonnucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs) representing eight diverse chemotypes have been correlated with their anti-HIV activities in an effort to establish simulation
Autor:
Julian Tirado-Rives, Sandra K. Ruby, Richard H. Smith, Marilyn B. Kroeger Smith, William L. Jorgensen, Christopher J. Michejda, Michelle Lamb
Publikováno v:
Protein Engineering, Design and Selection. 13:413-421
A computational model of the non-nucleoside inhibitor 8-Cl TIBO complexed with HIV-1 reverse transcriptase (RT) was constructed in order to determine the binding free energies. Using Monte Carlo simulations, both free energy perturbation and linear r
Autor:
Christopher J. Michejda, Edward Arnold, Paul A. J. Janssen, Stephen H. Hughes, Marilyn B. Kroeger Smith, Richard H. Smith
Publikováno v:
Journal of Molecular Structure: THEOCHEM. 423:67-77
In the past few years, drug research has focused on three HIV-1 enzymes, reverse transcriptase (RT), protease, and integrase. In the case of RT, a number of potent inhibitors have been discovered. These can be classified into two distinct groups, nuc
Autor:
Richard H. Smith, Jr.†,‡, Marilyn B. Kroeger Smith, and Christopher J. Michejda, Lisa A. Taneyhill
Publikováno v:
Chemical Research in Toxicology. 9:341-348
The base sequence selectivity of DNA alkylation for a series of structurally related 1,3-dialkyl-3-acyltriazenes was examined with calf thymus DNA or polymers containing the sequences GGG, CGC, TGT, and AGA. The reaction products at the N7 and the O6
Publikováno v:
The FASEB Journal. 22
Autor:
Julian Tirado-Rives, Richard H. Smith, Amanda M. Franklin, Emily V. Taylor, Kathryn D. Smith, Lenea H. Rader, Marilyn B. Kroeger Smith, William L. Jorgensen
Publikováno v:
Bioorganicmedicinal chemistry letters. 18(3)
The effect of mutations on amino acid residues L100, V106, and Y181 for unbound HIV-1 reverse transcriptase (RT) and RT bound to nevirapine and efavirenz was investigated using Monte Carlo/free energy perturbation calculations. Using both native and
Autor:
Wanyi Zhang, Christopher J. Michejda, Karen M. Watson, Eddy Arnold, John G. Julias, Marilyn B. Kroeger Smith, Thomas Roth, Robert W. Buckheit, Stephen H. Hughes, David W. Farnsworth, Marshall Morningstar, Kalyan Das
Publikováno v:
Journal of medicinal chemistry. 50(17)
In an ongoing effort to develop novel and potent nonnucleoside HIV-1 reverse transcriptase (RT) inhibitors that are effective against the wild type (WT) virus and clinically observed mutants, 1,2-bis-substituted benzimidazoles were synthesized and te
Publikováno v:
Current pharmaceutical design. 12(15)
While many inhibitors of the Human Immunodeficiency Virus (HIV), the causative agent of Acquired Immunodeficiency Syndrome (AIDS), have been developed, the problem of drug resistance has continued to plague the fight against the disease. The ability
Autor:
Sandra K. Ruby, Wanyi Zhang, William L. Jorgensen, Bryan Buckingham, Richard H. Smith, Stanislav Horouzhenko, Christopher J. Michejda, Ina Puleri, Stephen H. Hughes, Marilyn B. Kroeger Smith, Julia Richardson, Edward Arnold, Emily Potts
Publikováno v:
Drug design and discovery. 18(4)
The energies and physical descriptors for the binding of 21 novel 1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-benzimidazole (BPBI) analogs to HIV-1 reverse transcriptase (RT) variants Y181C, L100I, V106A, and K103N have been determined using Monte
Autor:
William L. Jorgensen, Paul A. J. Janssen, Richard H. Smith, Julian Tirado-Rives, Marilyn B. Kroeger Smith, Christopher J. Michejda, Michelle Lamb
Publikováno v:
Journal of medicinal chemistry. 41(26)
Monte Carlo (MC) simulations in combination with a linear response approach were used to estimate the free energies of binding for a series of 12 TIBO nonnucleoside inhibitors of HIV-1 reverse transcriptase. Separate correlations were made for the R6